Health Care
![a woman and man sitting on a bench](https://uschamber.imgix.net/https%3A%2F%2Fwww.uschamber.com%2Fassets%2Fimages%2FGettyImages-1062188098-Healthcare-Cover.jpg?auto=compress%2Cformat&fit=clip&fm=jpg&q=10&w=100&s=bfd8cc32727524536360f553c538881a)
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Latest
Report
The United States is currently grappling with a nursing shortage that is causing a ripple effect of rising health care costs and lower quality of life across the country.
Spotlight on Mental Health
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Related Litigation
Events
- InfrastructureGlobal Aerospace Summit 2024Tuesday, September 10 - Wednesday, September 1108:00 AM EDT - 05:00 PM EDTLearn More
- Employment PolicyReimagining Futures: Second Chance Employment ForumWednesday, September 1802:00 PM EDT - 07:00 PM EDTLearn More
- Corporate Social ResponsibilityBusiness Solves: Strengthening Communities, Today and TomorrowTuesday, October 29 - Wednesday, October 3009:00 AM EDT - 05:00 PM EDTLearn More
Latest Content
The health care reform ball is in the Senate’s court. Over the last few weeks, a working group has been hashing out a plan to repeal and replace Obamacare.
On Tuesday, June 6, 2017, this letter was sent to the members of the House Energy and Commerce Committee opposing any amendments that may be offered to H.R. 2430, the FDA Reauthorization Act (FDARA) of 2017, that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. The Committee will mark up the bill tomorrow morning. June 6, 2017 Dear Chairman Walden and Ranking Member Pallone:
On May 23, 2017, the U.S. Chamber of Commerce sent this letter to Senate Finance Committee Chairman Orrin Hatch that outlined several legislative reform recommendations as the Senate moves forward with crafting their own proposal for the repeal and replacement of Obamacare.
Consumers who buy their own insurance may soon be forced out of the market.
On Friday, May 19, the Chamber, along with 7 other trade associations representing insurers, hospitals, physicians and employers, sent a letter to U.S. Department of Health and Human Services Secretary Tom Price. The letter outlines serious concerns about the continued uncertainty around funding for cost-sharing reduction (CSR) payments and the negative impacts uncertainty will have on millions of Americans if it is not addressed.
On Friday, May 19, the Chamber, along with 7 additional trade associations representing insurers, hospitals, physicians and employers, sent a letter to Office of Management and Budget Director Mick Mulvaney. The letter outlines serious concerns about the continued uncertainty around funding for cost-sharing reduction (CSR) payments and the negative impacts uncertainty will have on millions of Americans if it is not addressed.
This letter was sent to the members of the House Subcommittee on Health opposing any amendments that may be offered to the Food and Drug Administration Reauthorization Act of 2017 that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. The Subcommittee is marking up the bill tomorrow morning. May 17, 2017
When Americans buy medication, the last thing they should worry about is whether they are getting what they paid for.
This letter was sent to the members of the Senate Committee on Health, Education, Labor, and Pensions opposing amendments that may be offered to S. 934, the Food and Drug Administration Reauthorization Act, that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. May 9, 2017